Presentation is loading. Please wait.

Presentation is loading. Please wait.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients  Anne-Laure Roux, Emilie Catherinot, Nathalie.

Published byRudolf Bell Modified over 6 years ago

Similar presentations

Presentation on theme: "Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients  Anne-Laure Roux, Emilie Catherinot, Nathalie."— Presentation transcript:

1 Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients  Anne-Laure Roux, Emilie Catherinot, Nathalie Soismier, Beate Heym, Gil Bellis, Lydie Lemonnier, Raphaël Chiron, Brigitte Fauroux, Muriel Le Bourgeois, Anne Munck, Isabelle Pin, Isabelle Sermet, Cristina Gutierrez, Nicolas Véziris, Vincent Jarlier, Emmanuelle Cambau, Jean-Louis Herrmann, Didier Guillemot, Jean-Louis Gaillard  Journal of Cystic Fibrosis  Volume 14, Issue 1, Pages (January 2015) DOI: /j.jcf Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

2 Fig. 1 BMI Z-score in the M. massiliense and M. abscessus groups.
Journal of Cystic Fibrosis  , 63-69DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

3 Fig. 2 Kinetics of mean BMI Z-score in the M. massiliense and M. abscessus groups. 0 is the year of the first mycobacterial isolation. Journal of Cystic Fibrosis  , 63-69DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

4 Fig. 3 Number of positive MABSC cultures and AFB smear positivity in cases with or without MABSC lung disease. AFB smear-positive cases were all cases with at least one positive AFB smear. Samples were obtained for a minimum period of 18months. Patients with a positive NTM sample had to submit three more sputum samples at monthly interval and then every 3months. Journal of Cystic Fibrosis  , 63-69DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

5 Fig. 4 Evolution of FEV1 in treated eradicated patients and treated non-eradicated patients in the M. massiliense and M. abscessus groups. Graphs are represented with individual curves. 0 is the year of first mycobacterial isolation. Journal of Cystic Fibrosis  , 63-69DOI: ( /j.jcf ) Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

Download ppt "Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients  Anne-Laure Roux, Emilie Catherinot, Nathalie."

Similar presentations

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations  Emilie Catherinot, Anne-Laure Roux, Marie-Anne.

Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations  Emilie Catherinot, Anne-Laure Roux, Marie-Anne.
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Bacterial contamination in the environment of hospitalised children with cystic fibrosis  Agnès Ferroni, Aurélie Werkhauser-Bertrand, Muriel Le Bourgeois,

Bacterial contamination in the environment of hospitalised children with cystic fibrosis  Agnès Ferroni, Aurélie Werkhauser-Bertrand, Muriel Le Bourgeois,
Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype  Nevine El Khatib, Agnes Ferroni,

Persistent Bordetella bronchiseptica infection in a child with cystic fibrosis: Relationship to bacterial phenotype  Nevine El Khatib, Agnes Ferroni,
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Cystic fibrosis mortality trends in France

Cystic fibrosis mortality trends in France
Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis  C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis  C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,
Pancreatic enzyme replacement therapy for young cystic fibrosis patients  Anne Munck, Jean-Francois Duhamel, Thierry Lamireau, Bernard Le Luyer, Claire.

Pancreatic enzyme replacement therapy for young cystic fibrosis patients  Anne Munck, Jean-Francois Duhamel, Thierry Lamireau, Bernard Le Luyer, Claire.
Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!  Clémence Martin, Cécile Hamard,

Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!  Clémence Martin, Cécile Hamard,
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 

E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis  M. Proesmans, F. Vermeulen,

Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis  M. Proesmans, F. Vermeulen,
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.

Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation  Kris De Boeck, Anne Munck, Seth Walker, Albert Faro,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 

Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of.
Cirrhosis and other liver disease in cystic fibrosis

Cirrhosis and other liver disease in cystic fibrosis
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
John Widger, Sarath Ranganathan, Philip J. Robinson 

John Widger, Sarath Ranganathan, Philip J. Robinson 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.

Similar presentations

Ads by Google